Aptose Biosciences Stock Market Value

APS Stock  CAD 5.22  0.43  8.98%   
Aptose Biosciences' market value is the price at which a share of Aptose Biosciences trades on a public exchange. It measures the collective expectations of Aptose Biosciences investors about its performance. Aptose Biosciences is selling at 5.22 as of the 16th of March 2025; that is 8.98 percent increase since the beginning of the trading day. The stock's open price was 4.79.
With this module, you can estimate the performance of a buy and hold strategy of Aptose Biosciences and determine expected loss or profit from investing in Aptose Biosciences over a given investment horizon. Check out Aptose Biosciences Correlation, Aptose Biosciences Volatility and Aptose Biosciences Alpha and Beta module to complement your research on Aptose Biosciences.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
Symbol

Aptose Biosciences Price To Book Ratio

Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aptose Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aptose Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aptose Biosciences.
0.00
12/16/2024
No Change 0.00  0.0 
In 2 months and 31 days
03/16/2025
0.00
If you would invest  0.00  in Aptose Biosciences on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Aptose Biosciences or generate 0.0% return on investment in Aptose Biosciences over 90 days. Aptose Biosciences is related to or competes with Medicenna Therapeutics, and Oncolytics Biotech. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressin... More

Aptose Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aptose Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aptose Biosciences upside and downside potential and time the market with a certain degree of confidence.

Aptose Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptose Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aptose Biosciences' standard deviation. In reality, there are many statistical measures that can use Aptose Biosciences historical prices to predict the future Aptose Biosciences' volatility.
Hype
Prediction
LowEstimatedHigh
0.244.89526.89
Details
Intrinsic
Valuation
LowRealHigh
0.163.25525.26
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-13.43-10.71-8
Details

Aptose Biosciences Backtested Returns

Aptose Biosciences is out of control given 3 months investment horizon. Aptose Biosciences secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-nine different technical indicators, which can help you to evaluate if expected returns of 15.98% are justified by taking the suggested risk. Use Aptose Biosciences Mean Deviation of 88.36, downside deviation of 8.97, and Risk Adjusted Performance of 0.1168 to evaluate company specific risk that cannot be diversified away. Aptose Biosciences holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -21.12, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aptose Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Aptose Biosciences is expected to outperform it. Use Aptose Biosciences semi variance, and the relationship between the maximum drawdown and accumulation distribution , to analyze future returns on Aptose Biosciences.

Auto-correlation

    
  -0.43  

Modest reverse predictability

Aptose Biosciences has modest reverse predictability. Overlapping area represents the amount of predictability between Aptose Biosciences time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aptose Biosciences price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Aptose Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient-0.43
Spearman Rank Test-0.41
Residual Average0.0
Price Variance4.74

Aptose Biosciences lagged returns against current returns

Autocorrelation, which is Aptose Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aptose Biosciences' stock expected returns. We can calculate the autocorrelation of Aptose Biosciences returns to help us make a trade decision. For example, suppose you find that Aptose Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Aptose Biosciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aptose Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aptose Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aptose Biosciences stock over time.
   Current vs Lagged Prices   
       Timeline  

Aptose Biosciences Lagged Returns

When evaluating Aptose Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aptose Biosciences stock have on its future price. Aptose Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aptose Biosciences autocorrelation shows the relationship between Aptose Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Aptose Biosciences.
   Regressed Prices   
       Timeline  

Pair Trading with Aptose Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aptose Stock

  0.76BRK Berkshire Hathaway CDRPairCorr

Moving against Aptose Stock

  0.81AMZN Amazon CDRPairCorr
  0.79GOOG Alphabet CDRPairCorr
  0.72MSFT Microsoft Corp CDRPairCorr
  0.69BOFA Bank of AmericaPairCorr
  0.43GS GOLDMAN SACHS CDRPairCorr
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock:
Check out Aptose Biosciences Correlation, Aptose Biosciences Volatility and Aptose Biosciences Alpha and Beta module to complement your research on Aptose Biosciences.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Aptose Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aptose Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aptose Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...